After completion of an asthma outreach program in three communities in the Navajo Nation, the odds for routine asthma care ...

This study shows that specific ratios of circulating sphingolipids to steroids can predict the risk of future asthma ...

In patients with cystic fibrosis, CMTX-101, an immune-enabling antibody therapy, lowered four inflammatory biomarkers and ...

The phase 2a trial showed GR-0621 met primary and secondary endpoints, demonstrating safety and efficacy over 12 weeks. Phase 2a data show oral GRI-0621 was safe and improved immune and fibrosis ...